1. Home
  2. SEPN vs RYET Comparison

SEPN vs RYET Comparison

Compare SEPN & RYET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • RYET
  • Stock Information
  • Founded
  • SEPN 2022
  • RYET 2012
  • Country
  • SEPN United States
  • RYET China
  • Employees
  • SEPN N/A
  • RYET N/A
  • Industry
  • SEPN
  • RYET
  • Sector
  • SEPN
  • RYET
  • Exchange
  • SEPN NYSE
  • RYET NYSE
  • Market Cap
  • SEPN 311.6M
  • RYET 271.4M
  • IPO Year
  • SEPN 2024
  • RYET 2025
  • Fundamental
  • Price
  • SEPN $6.69
  • RYET $9.45
  • Analyst Decision
  • SEPN Buy
  • RYET
  • Analyst Count
  • SEPN 4
  • RYET 0
  • Target Price
  • SEPN $33.00
  • RYET N/A
  • AVG Volume (30 Days)
  • SEPN 181.2K
  • RYET 559.9K
  • Earning Date
  • SEPN 05-19-2025
  • RYET 01-01-0001
  • Dividend Yield
  • SEPN N/A
  • RYET N/A
  • EPS Growth
  • SEPN N/A
  • RYET N/A
  • EPS
  • SEPN N/A
  • RYET N/A
  • Revenue
  • SEPN $1,075,000.00
  • RYET $6,989,985.00
  • Revenue This Year
  • SEPN N/A
  • RYET N/A
  • Revenue Next Year
  • SEPN N/A
  • RYET N/A
  • P/E Ratio
  • SEPN N/A
  • RYET N/A
  • Revenue Growth
  • SEPN 611.92
  • RYET N/A
  • 52 Week Low
  • SEPN $4.17
  • RYET $4.00
  • 52 Week High
  • SEPN $28.99
  • RYET $8.92
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • RYET N/A
  • Support Level
  • SEPN N/A
  • RYET N/A
  • Resistance Level
  • SEPN N/A
  • RYET N/A
  • Average True Range (ATR)
  • SEPN 0.00
  • RYET 0.00
  • MACD
  • SEPN 0.00
  • RYET 0.00
  • Stochastic Oscillator
  • SEPN 0.00
  • RYET 0.00

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About RYET RUANYUN EDAI TECHNOLOGY INC

Ruanyun Edai Technology Inc is primarily engaged in providing online academic exercise question banks with A.I. capabilities, online classes and homework, and on-demand lectures and evaluations that cover all K-12 subject fields and grade levels.

Share on Social Networks: